Pembrolizumab plus Lenvatinib Combination Therapy for Advanced Endometrial Carcinoma
AuthID
P-00Y-5RQ
P-00Y-5RQ
© 2024 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service